ELVN-001 demonstrates encouraging anti-CML activity in heavily pretreated patients with atypical fusion transcripts Growing unmet need for patients with atypical transcript e13a3, which is resistant to TKIs targeting the myristoyl pocket BOULDER, Colo., Nov. 3, 2025 /PRNewswire/ –…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
At 7987 S. Broadway LITTLETON, Colo., Jan. 10, 2023 /PRNewswire/ — Rocky Mountain Spine & Sport Physical Therapy opened a second Littleton outpatient clinic Monday at 7987 S. Broadway. The Littleton-Southpark clinic, as it is […]
Robin Harper Cowie of Biodesix, Inc. and Lyndsey Linke of SiVEC Biotechnologies, Inc. Represent the Momentum of State’s Life Sciences Community Denver – Colorado BioScience Association (CBSA), which creates co-opportunity for Colorado’s life sciences community […]
BOULDER, Colo.–(BUSINESS WIRE)– #Biomarker–IDT’s suite of NGS innovations aim to tackle longstanding bottlenecks in library preparation, targeted enrichment, and whole genome analysis. Click here to view original post Click Here to Publish/Feature Your Company or […]
Copyright © 2026 Biotech Networks
